Is Nephro Care India Ltd (NEPHROCARE) a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Nephro Care India Ltd is a average quality company .

Is Nephro Care India Ltd (NEPHROCARE) undervalued or overvalued?

The key valuation ratios of Nephro Care India Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone .

What is Nephro Care India Ltd (NEPHROCARE) share price return in the past 10 years?

Data is not available for this company

Is Nephro Care India Ltd (NEPHROCARE) a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Strong which suggest that the price of Nephro Care India Ltd is likely to Rise in the short term. However, please check the rating on Quality and Valuation before investing

What is the share price of Nephro Care India Ltd (NEPHROCARE)?

Company share prices are keep on changing according to the market conditions. The current trading price of Nephro Care India Ltd (NEPHROCARE) on 01-Jan-1970 05:30:00 at 05:30 is .

What is the market cap of Nephro Care India Ltd (NEPHROCARE)?

Market capitalization is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jan-1970 at 05:30, the market cap of Nephro Care India stood at Rs. 141.87 Cr.

What is the P/E ratio of Nephro Care India?

The latest standalone P/E ratio of Nephro Care India as of 01-Jan-1970 is 38.99.

What is the P/B ratio of Nephro Care India Ltd (NEPHROCARE)?

The latest standalone P/B ratio of Nephro Care India Ltd (NEPHROCARE) as of 01-Jan-1970 is 2.63.

What is the 52-week high and low of Nephro Care India Ltd (NEPHROCARE)?

The 52-week high of Nephro Care India Ltd (NEPHROCARE) is Rs. 0.00 and the 52-week low is Rs. 0.00.

What is the TTM revenue of Nephro Care India Ltd (NEPHROCARE)?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Nephro Care India is Rs. 46.03 (Cr.).

Nephro Care India Ltd (NEPHROCARE) Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: Nephro Care India Ltd (NEPHROCARE)
Brand: Nephro Care India

10 Year X-Ray :

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	21.1%	0.9%	65.7%	63%	14.4%	-
Value Creation Index ⓘ	0.5	-0.9	3.7	3.5	0.0	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	1.8	3.4	17.1	27.2	46	46
Sales YoY Gr.	-	87.9%	399.7%	59.3%	69%	-
Adj EPS ⓘ	4.4	-0	2.4	3.6	1.8	2.2
YoY Gr.	-	-100.2%	NA	53.2%	-51.8%	-
BVPS (₹) ⓘ	0.8	0.5	2.5	12.6	32.4	32.7
Adj Net Profit ⓘ	0.1	-0	2.4	4.3	2.9	4
Cash Flow from Ops. ⓘ	0.2	0.6	4.1	0.9	7.8	-
Debt/CF from Ops. ⓘ	3.1	4.1	0.6	0	0	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	NA	NA	137.9%	69%
Adj EPS ⓘ	NA	NA	NA	-51.8%
BVPSⓘ	NA	NA	301.8%	157.1%
Share Price	-	-	-	-44.4%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	591.3	-3.8	156.9	49.2	8.4	6.8
Op. Profit Mgn % ⓘ	8.5	3.7	20	23.8	12.8	8.5
Net Profit Mgn % ⓘ	4.9	-0.3	13.9	15.9	6.3	7.9
Debt to Equity ⓘ	46.2	5.1	1	0	0	-
Working Cap Days ⓘ	0	46	17	56	81	0
Cash Conv. Cycle ⓘ	0	-26	-10	-20	-9	0

Recent Performance Summary

Sales growth is growing at healthy rate in last 3 years 137.87%

Return on Equity has declined versus last 3 years average to 6.80%

Net Profit has been subdued in last 3 years 0.00%

Sales growth is not so good in last 4 quarters at 0.00%

	Standalone	Consolidated
TTM EPS (₹)	2.2	-
TTM Sales (₹ Cr.)	46	-
BVPS (₹) ⓘ	32.7	-
Reserves (₹ Cr.) ⓘ	37	-
P/BV ⓘ	2.63	-
PE ⓘ	38.99	-

From the Market
52 Week Low / High (₹)	0.00 / 0.00
All Time Low / High (₹)	- / -
Market Cap (₹ Cr.)	142
Equity (₹ Cr.)	16.5
Face Value (₹)	10
Industry PE ⓘ	86.1

PARTICULARS	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	2	3	17	27	46
Operating Expenses ⓘ +	2	3	14	21	40
Manufacturing Costs	0	1	6	7	12
Material Costs	1	1	5	9	13
Employee Cost	0	0	1	2	8
Other Costs ⓘ	0	1	1	2	7
Operating Profit ⓘ	0	0	3	6	6
Operating Profit Margin (%)	8.5%	3.7%	20.0%	23.7%	12.8%
Other Income ⓘ +	0	0	0	0	2
Exceptional Items ⓘ	0	0	0	0	0
Interest ⓘ	0	0	0	0	0
Depreciation ⓘ	0	0	1	1	2
Profit Before Tax ⓘ	0	0	3	6	5
Tax ⓘ	0	0	0	2	1
Profit After Tax	0	-0	2	5	4
PAT Margin (%)	4.9%	-0.3%	13.9%	16.5%	7.9%
Adjusted EPS (₹)	4.4	-0.0	2.4	3.8	2.2
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%

PARTICULARS	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	0	0	3	15	53
Share Capital ⓘ	0	1	1	12	16
Reserves ⓘ	0	-0	2	3	37
Debt +	1	2	2	0	0
Long Term Debt	1	2	2	0	0
Short Term Debt	0	0	0	0	0
Minority Interest	0	0	0	0	0
Trade Payables	0	0	1	2	4
Others Liabilities ⓘ	0	1	2	4	11
Total Liabilities ⓘ	1	5	8	21	68
Fixed Assets
Net Fixed Assets ⓘ +	0	1	3	5	31
Gross Block	0	2	4	6	35
Accumulated Depreciation	0	0	1	1	4
CWIP ⓘ	0	2	0	1	1
Investments ⓘ	0	0	2	7	19
Inventories	0	0	0	0	1
Trade Receivables	0	0	0	0	3
Cash Equivalents	0	1	2	1	5
Others Assets ⓘ	0	0	0	7	8
Total Assets ⓘ	1	5	8	21	68

PARTICULARS	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	0	1	4	1	8
PBT ⓘ	0	0	3	6	5
Adjustment ⓘ	0	0	1	0	1
Changes in Working Capital ⓘ	0	1	1	-3	3
Tax Paid ⓘ	0	-0	-0	-2	-1
Cash Flow From Investing Activity ⓘ +	-0	-3	-2	-8	-40
Capex	-0	-1	-1	-2	-29
Net Investments	0	0	-2	-4	-10
Others ⓘ	0	-1	0	-1	-0
Cash Flow From Financing Activity ⓘ +	0	2	-0	6	35
Net Proceeds from Shares ⓘ	0	0	0	8	35
Net Proceeds from Borrowing ⓘ	0	0	0	0	0
Interest Paid ⓘ	-0	-0	-0	-0	0
Dividend Paid ⓘ	0	0	0	0	0
Others ⓘ	0	2	-0	-2	0
Net Cash Flow ⓘ	0	0	2	-1	3

PARTICULARS	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	N/A	N/A	156.92	51.3	10.62
ROCE (%)	N/A	N/A	65.72	62.97	14.42
Asset Turnover Ratio	1.62	1.19	2.67	1.87	1.03
PAT to CFO Conversion(x)	N/A	N/A	2	0.2	2
Working Capital Days
Receivable Days	0	21	3	1	13
Inventory Days	5	10	7	6	6
Payable Days	94	96	51	57	80

About Nephro Care India Ltd

Nephro Care India was originally incorporated on July 08, 2014 as a Private Limited Company as ‘Nephro Care India Private Limited’ under the provisions of the Companies Act, 2013 with the Registrar of Companies, West Bengal. Subsequently, the Company was converted into a public limited company pursuant to a resolution passed by its Shareholders at an extraordinary general meeting held on December 26, 2023 and consequently the name of the Company was changed to ‘Nephro Care India Limited’ and a fresh certificate of incorporation dated March 5, 2024, was issued by the Registrar of Companies, Central Processing Centre.

Nephro Care India was founded in the year 2014 in Kolkata with an object of providing comprehensive medical services for renal patients. The company is a one stop treatment centre based in Kolkata that offers a wide range of clinical and lifestyle solutions and services and renal insufficiency treatment to patients. The treatment framework covers the entire range of lifestyle, physiological and spiritual aspects of wellness. The operations of Nephro Care are supported by a pool of expert Doctors, experienced and well-trained paramedical professionals and a skilled management team. The entire team at Nephro Care is supported by sufficient clinical and investigative infrastructure. At Nephro Care treatment regimens are planned and practiced on the basis of core scientific understanding, transparency and ethics.

Its vision is to reach out to the masses through a holistic approach combining modern medicine with time tested yogic wisdom to touch the lives of one million kidney disease patients across the country by leveraging its hub-and-spoke model. Its clinics are equipped with technologically advanced equipment and diagnostic instruments. It has a wide spec of diagnostic facilities to provide its doctors freedom to explore all diagnostic possibilities and offer its patients a better service and care under one roof and to also ensure optimum clinical outcomes.

Business area of the company

Nephro Care India is a healthcare provider that specializes in the treatment of kidney-related diseases. Its team of experienced nephrologists and healthcare professionals are dedicated to providing its patients with the highest quality care and treatment. The company also offers holistic treatment plans tailored to meet the unique needs of each patient.

Services of the company

Conservative Nephrology
Renal Transplant Clinic
Urology Clinic
Vascular Surgery Clinic
Hemodialisis
Clinical Nutrition and Lifestyle Education
Lifestyle and Rehabilitation Program
Carepath Diagnostics
Digital Radiology
Cardiology
O.T. Facility
Women Welfare

Awards and accreditations

2023: Its Salt Lake Clinic has been recognized as the ‘Award of Excellence from Health Conclave’ by Zee 24 Ghanta.
2024: Best Single Speciality Clinic in Nephrological Care from The Times of India (the Power Icon award).
2025: The company has secured 24 Ghonta Health Conclave 2025 award as the ‘Excellence in Emerging Multispecialty Hospital’
2025: The company has secured ET Now Business Excellence award for ‘Best Single Speciality Kidney Care Centre’.
2025: The company has been recognized in ET Now Industry Icons 2025 for ‘Best Emerging Smart Multi-Speciality Hospital’ and ‘Emerging Smart Multi-Speciality Hospital’.
2025: The company has secured Duars Ustab awards
2025: Times Network Business Excellence Award for ‘Best Single Speciality Kidney Care Centre’

History and milestones

2014: Incorporated as Nephro Care India Private Limited
2021: Commencement of its flagship Salt Lake, Kolkata clinic
2023: Commencement of two satellite clinics at Chandannagar, West Bengal 2024 Converted into Nephro Care India Limited.
2024-25: Launched its Initial Public Offering (IPO).
2024-25: Inaugurated its flagship facility ‘Vivacity Multispecialty Hospital’ in Madhyamgram, Kolkata.

Build a Stress-Tested Portfolio.

Our Sapphire Advisory uses the ABC Concept to ensure you never have to panic during a market correction.

Core Stocks

STABILITY

Booster Stocks

GROWTH

Amplifier Stocks

ASYMMETRY

● Conflict-Free ● SEBI Registered ● 15Y+ Track Record

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Nephro Care India Ltd (NEPHROCARE) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating